NuVasive

Rank: 64
2016 Rank73
Employees2,200
Revenue:$962,072,000
R&D Spend:$47,999,000
Fiscal year ending:12-31-16
Click here to see all 100

NuVasive, Inc. (NASDAQ: NUVA) (“NuVasive or the “Company”), a leading medical device company focused on transforming spine surgery with minimally disruptive, procedurally integrated solutions, today announced the launch of its Integrated Global Alignment (iGA) platform. - See more at: http://www.nuvasive.com/about-us/newsroom/#sthash.051QkkuH.dpuf

NuVasive Launches Next Generation Biologics Technology. NuVasive Announces Regulatory Approval of Reline Posterior Fixation Technology in Japan. NuVasive to Acquire Ellipse Technologies. NuVasive Receives First Ever FDA 510(k) Clearance of Cervical Corpectomy Cage. NuVasive(R) Reaches Agreement in Principle to Settle OIG Matter.

Big 100 Mini Logo Key Personnel: Gregory Lucier, chairman & CEO; Patrick Miles, vice chairman; Matt Link, EVP, strategy, technology & corporate development; Quentin Blackford, EVP & CFO; Carol Cox, EVP, external affairs; Pete Leddy, EVP, global HR, integrations, global risk & integrity, real estate and internal communications & culture; Skip Kiil, EVP, global commercial; Steve Rozow, EVP, global process transformation; Joan Stafslien, EVP, GC & corporate secretary.;

7475 Lusk Blvd.
San Diego, California
92121
USA